Drug Combo Fails to Improve Mesothelioma Survival
Adding the VEGF-inhibitor bevacizumab to a popular chemotherapy combination for mesothelioma does not appear to prolong survival after all. Scientists at 11…
New drugs for mesothelioma, improvements in diagnostic tools and clinical trials give cancer patients more than a fighting chance. Read now.